Comparing the results of bisphosphonate use in clinical trials with actual practice: a case of apples and oranges?

por Gainford, M.C., Dranitsaris, G., Ooi, W., Vanhuyse, M., Clemons, M.
Publicado 2006

Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib

por Dranitsaris, G., Vincent, M. D., Yu, J., Huang, L., Fang, F., Lacouture, M. E.
Publicado 2012

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

por Simmons, C., Miller, N., Geddie, W., Gianfelice, D., Oldfield, M., Dranitsaris, G., Clemons, M. J.
Publicado 2009

Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis

por Ryan, P, McBride, A, Ray, D, Pulgar, S, Ramirez, RA, Elquza, E, Favaro, JP, Dranitsaris, G
Publicado 2019

Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients

por Amir, E, Freedman, OC, Chia, S, Petrella, T, Dent, S, Tonkin, K, Ahmad, I, Rayson, D, Dranitsaris, G, Clemons, M
Publicado 2009

A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and nonsteroidal (anastrozole) aromatase inhibitors on biomarker...

por Freedman, OC, Amir, E, Dranitsaris, G, Dowsett, M, Cole, DEC, Kahn, H, O'Malley, F, Verma, S, Clemons, M
Publicado 2009

The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting

por Dranitsaris, G., Molassiotis, A., Clemons, M., Roeland, E., Schwartzberg, L., Dielenseger, P., Jordan, K., Young, A., Aapro, M.
Publicado 2017

Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes

por Gibson, EJ, Begum, N, Koblbauer, I, Dranitsaris, G, Liew, D, McEwan, P, Tahami Monfared, AA, Yuan, Y, Juarez-Garcia, A, Tyas, D, Lees, M
Publicado 2018

Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea

por Maroun, J.A., Anthony, L.B., Blais, N., Burkes, R., Dowden, S.D., Dranitsaris, G., Samson, B., Shah, A., Thirlwell, M.P., Vincent, M.D., Wong, R.
Publicado 2007

A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting

por Clemons, M., Dranitsaris, G., Sienkiewicz, M., Sehdev, S., Ng, T., Robinson, A., Mates, M., Hsu, T., McGee, S., Freedman, O., Kumar, V., Fergusson, D., Hutton, B., Vandermeer, L., Hilton, J.
Publicado 2020